Influenza, Human
Welcome,         Profile    Billing    Logout  
 66 Companies   64 Products   64 Products   38 Mechanisms of Action   0 Trials   1523 News 


«12345678910111213...3031»
  • ||||||||||  Agriflu (trivalent influenza virus vaccine) / CSL Behring, FLUAD (trivalent inactivated influenza vaccine) / CSL Behring
    Trial completion, IO biomarker:  ADITEC FLU STUDY: Understanding the Genetic Basis for Immune Responses (clinicaltrials.gov) -  Jul 9, 2015   
    P2,  N=90, Completed, 
    Recruiting --> Completed | N=320 --> 205 Active, not recruiting --> Completed
  • ||||||||||  Trial primary completion date:  Use of Probiotics to Prevent Influenza (clinicaltrials.gov) -  Jul 6, 2015   
    P=N/A,  N=1440, Recruiting, 
    Active, not recruiting --> Completed Trial primary completion date: May 2015 --> Dec 2015
  • ||||||||||  Vaxigrip (inactivated influenza vaccine (split virion)) / Sanofi
    Enrollment open, Trial initiation date, Trial primary completion date, Adverse events:  IVVE:Pilot: Influenza Vaccine To Prevent Adverse Vascular Events:Pilot (clinicaltrials.gov) -  Jul 6, 2015   
    P2,  N=600, Recruiting, 
    Trial primary completion date: May 2015 --> Dec 2015 Not yet recruiting --> Recruiting | Initiation date: Oct 2014 --> Apr 2015 | Trial primary completion date: Dec 2014 --> Dec 2015
  • ||||||||||  Enrollment open, Trial primary completion date:  A Randomized Trial of Vitamin D to Reduce Respiratory Infection (clinicaltrials.gov) -  Jul 6, 2015   
    P=N/A,  N=300, Recruiting, 
    Not yet recruiting --> Recruiting | Initiation date: Oct 2014 --> Apr 2015 | Trial primary completion date: Dec 2014 --> Dec 2015 Active, not recruiting --> Recruiting | Trial primary completion date: Jan 2014 --> Jun 2016
  • ||||||||||  FluMist (influenza vaccine, live, intranasal) / AstraZeneca, FluMist Quadrivalent (live attenuated influenza vaccine nasal spray) / AstraZeneca, Daiichi Sankyo, Vaxigrip (inactivated influenza vaccine (split virion)) / Sanofi
    Enrollment closed, Trial primary completion date:  Live Versus Inactivated Influenza Vaccine Study in Hutterite Children (clinicaltrials.gov) -  Jul 6, 2015   
    P4,  N=3800, Active, not recruiting, 
    Active, not recruiting --> Recruiting | Trial primary completion date: Jan 2014 --> Jun 2016 Recruiting --> Active, not recruiting | Trial primary completion date: Apr 2015 --> Dec 2015
  • ||||||||||  Fluzone (influenza vaccine) / Sanofi
    Enrollment change, Trial primary completion date:  Immune and Hormone Response to Influenza Vaccine (clinicaltrials.gov) -  Jul 2, 2015   
    P4,  N=100, Active, not recruiting, 
    Recruiting --> Active, not recruiting | Trial primary completion date: Apr 2015 --> Dec 2015 N=40 --> 100 | Trial primary completion date: Aug 2014 --> Aug 2017
  • ||||||||||  Trial completion, Trial primary completion date:  Phase III Study of Intramuscular TAK-816 in Healthy Infants (clinicaltrials.gov) -  Jun 17, 2015   
    P3,  N=31, Completed, 
    Trial primary completion date: Mar 2015 --> Dec 2015 Recruiting --> Completed | Trial primary completion date: Sep 2015 --> Mar 2015
  • ||||||||||  Trial primary completion date:  4 Pillars Toolkit for Adolescent Vaccination (clinicaltrials.gov) -  Jun 11, 2015   
    P=N/A,  N=21, Active, not recruiting, 
    Trial primary completion date: Apr 2015 --> Jun 2016 Trial primary completion date: Mar 2015 --> May 2016
  • ||||||||||  Enrollment change, Trial termination:  Influenza Vaccination in Cancer Patients (clinicaltrials.gov) -  Jun 11, 2015   
    P=N/A,  N=97, Terminated, 
    Trial primary completion date: Jun 2014 --> Jun 2016 N=130 --> 97 | Recruiting --> Terminated; Insufficient enrollment
  • ||||||||||  Enrollment closed, Trial primary completion date:  Influenza Immunization of Children in India (clinicaltrials.gov) -  Jun 10, 2015   
    P4,  N=3600, Active, not recruiting, 
    Recruiting --> Completed Recruiting --> Active, not recruiting | Trial primary completion date: Sep 2014 --> Dec 2015
  • ||||||||||  Trial completion, Enrollment change, Trial primary completion date:  CollabFlu: Collaborative Efforts to Increase Flu Vaccination (clinicaltrials.gov) -  Jun 2, 2015   
    P=N/A,  N=117175, Completed, 
    Suspended --> Completed | Trial primary completion date: Mar 2011 --> Mar 2014 Active, not recruiting --> Completed | N=85000 --> 117175 | Trial primary completion date: Aug 2012 --> Feb 2015
  • ||||||||||  FluMist Quadrivalent (live attenuated influenza vaccine nasal spray) / AstraZeneca, Daiichi Sankyo
    Trial completion, Trial primary completion date:  RELATIVES: Randomized Controlled Trial of LAIV vs TIV Vaccines in Schools (clinicaltrials.gov) -  May 27, 2015   
    P=N/A,  N=902, Completed, 
    Recruiting --> Active, not recruiting | Trial primary completion date: Nov 2014 --> Sep 2015 Active, not recruiting --> Completed | Trial primary completion date: Mar 2015 --> Jan 2014
  • ||||||||||  Vaxigrip (inactivated influenza vaccine (split virion)) / Sanofi
    Trial completion, Trial primary completion date:  Intradermal Versus Intramuscular Trivalent Influenza Vaccine in Adult Solid Organ Transplant Recipients (clinicaltrials.gov) -  May 27, 2015   
    P=N/A,  N=229, Completed, 
    Active, not recruiting --> Completed | Trial primary completion date: Mar 2015 --> Jan 2014 Active, not recruiting --> Completed | Trial primary completion date: Apr 2012 --> Aug 2012
  • ||||||||||  Fluzone High-Dose Quadrivalent (influenza vaccine) / Evotec, Sanofi
    Enrollment closed:  Immunogenicity of Fluzone High Dose in Immunocompromised Children and Young Adults (clinicaltrials.gov) -  May 27, 2015   
    P2,  N=360, Active, not recruiting, 
    Active, not recruiting --> Completed | Trial primary completion date: Apr 2012 --> Aug 2012 Recruiting --> Active, not recruiting
  • ||||||||||  VIS410 / Otsuka
    Trial completion, Enrollment change:  A Study of VIS410 to Assess Safety and Pharmacokinetics (clinicaltrials.gov) -  May 14, 2015   
    P1,  N=41, Completed, 
    Active, not recruiting --> Completed Recruiting --> Completed | N=54 --> 41
  • ||||||||||  pimodivir (JNJ-3872) / J&J
    Trial primary completion date, Combination therapy, Monotherapy:  Study of Acute Uncomplicated Seasonal Influenza A in Adult Subjects (clinicaltrials.gov) -  May 6, 2015   
    P2,  N=500, Active, not recruiting, 
    Not yet recruiting --> Recruiting Trial primary completion date: Apr 2015 --> May 2016
  • ||||||||||  Enrollment change, Trial initiation date, Trial withdrawal:  GSH Supplementation on Cold/Flu Symptoms in Older Healthy Adults (clinicaltrials.gov) -  May 6, 2015   
    P=N/A,  N=0, Withdrawn, 
    Trial primary completion date: Apr 2015 --> May 2016 N=120 --> 0 | Initiation date: Jan 2015 --> May 2015 | Not yet recruiting --> Withdrawn
  • ||||||||||  Trial completion:  IIJI: Inactivated Influenza Via Jet Injection (clinicaltrials.gov) -  Apr 30, 2015   
    P4,  N=985, Completed, 
    Recruiting --> Completed Recruiting --> Completed
  • ||||||||||  Pentacel (diphtheria and tetanus toxoids and acellular pertussis adsorbed, inactivated poliovirus and hemophilus b conjugate) / Sanofi, Menactra (Meningococcal-groups A, C, Y and W-135 polysaccharide diphtheria toxoid conjugate vaccine) / Sanofi
    Trial primary completion date:  Study of Menactra (clinicaltrials.gov) -  Apr 23, 2015   
    P4,  N=1394, Active, not recruiting, 
    Active, not recruiting --> Completed Trial primary completion date: Sep 2015 --> Nov 2014
  • ||||||||||  Trial primary completion date:  Immune Responses Induced by Different Licensed Influenza Vaccines (clinicaltrials.gov) -  Apr 22, 2015   
    P=N/A,  N=36, Active, not recruiting, 
    Trial primary completion date: Sep 2015 --> Nov 2014 Trial primary completion date: Mar 2015 --> Apr 2016
  • ||||||||||  Enrollment change:  Rapid Diagnostic Test for Influenza (clinicaltrials.gov) -  Apr 21, 2015   
    P=N/A,  N=569, Completed, 
    Trial primary completion date: Mar 2015 --> Apr 2016 N=1000 --> 569